Table 2

Arthroscopic VAS assessments (mm), observer scoring overall synovitis before and after dosing with intra-articular primatised anti-CD4 monoclonal antibody

		Arthroscopic VAS for synovitis before dose	Arthroscopic VAS for synovitis after dose	Difference in scores
Treatment groups	Placebo	69	76	7
	0 mg	67	70	−3
	median	68	73	−5
	0.4 mg	64	60	4
		86	48	38
		64	37	27
	median	64	48	27
	40 mg	89	71	28
		80	58	22
		76	47	29
		93	41	52
		77	63	14
		83	73	10
		71	61	10
	median	80	61	22